Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Catherine Mackey
AddedFeb 15, 2024
UpdatedMay 31, 2026
Catherine Mackey

Catherine Mackey

Board Member, Ideaya Biosciences

LinkedIn

Catherine Mackey's Career

Ideaya Biosciences
Ideaya Biosciences

South San Francisco, CA, US

Board Member· Board
Fhoosh
Fhoosh

Los Angeles, CA, US

Board Member· Board
Evolve Biosystems
Evolve Biosystems

Davis, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Catherine Mackey's Career

Ideaya Biosciences
Ideaya Biosciences
Public$431.1M1032015South San Francisco, CA, US
Board Member· Board

Leadership at Ideaya Biosciences

Jeff HagerJeff HagerCo-Founder
Scott MorrisonScott MorrisonBoard Member
Garret HamptonGarret HamptonBoard Member
Terry RosenTerry RosenBoard Member
Tim ShannonTim ShannonBoard Member
Thilo SchroederThilo SchroederBoard Member

Similar to Ideaya Biosciences

Synnovation TherapeuticsSynnovation TherapeuticsWilmington, DE, USOncology Therapiesest. 2021Synnovation TherapeuticsWilmington, DE, US · est. 2021

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

Series A · $139M18
Immune-Onc TherapeuticsImmune-Onc TherapeuticsPalo Alto, CA, USCancer Treatmentest. 2016Immune-Onc TherapeuticsPalo Alto, CA, US · est. 2016

California-based Immune-Onc Therapeutics develops therapeutic antibodies for cancer treatment.

Public · $140.1M35
Sutro BiopharmaSutro BiopharmaSouth San Francisco, CA, USCancer Therapeuticsest. 2003Sutro BiopharmaSouth San Francisco, CA, US · est. 2003

Sutro Biopharma, a California-based medical firm, develops and manufactures cancer therapy drugs.

Public · $561.6M278
Akoya BiosciencesAkoya BiosciencesMarlborough, MA, USSpatial Biologyest. 2015Akoya BiosciencesMarlborough, MA, US · est. 2015

Akoya Biosciences: Providing global spatial biology solutions for precise immuno-oncology therapies.

Public · $127M369
Fhoosh
Fhoosh
Seed$2M302012Los Angeles, CA, US
Board Member· Board

Leadership at Fhoosh

Linda EignerLinda EignerCo-Founder
Eric TobiasEric TobiasCo-Founder

Similar to Fhoosh

FortresswareFortresswareLos Altos, CA, USData Security, Softwareest. 2004FortresswareLos Altos, CA, US · est. 2004

Fortressware, Inc.: A California-based data security provider offering comprehensive solutions to protect intellectual property.

Series A · $2.5M5
KineticFuseKineticFuseTampa, FL, USCybersecurity, Data Securityest. 2018KineticFuseTampa, FL, US · est. 2018

KineticFuse: A cybersecurity company safeguarding your data against elite cyber threats.

Pre-Seed · $700k30
HushHushDetroit, MI, USCybersecurity, Privacy Managementest. 2021HushDetroit, MI, US · est. 2021

Hush: A trusted AI-powered cybersecurity service, providing comprehensive digital privacy and threat protection.

Seed · $6.1M30
Evolve Biosystems
Evolve Biosystems
Series D$125M392011Davis, CA, US
Board Member· Board

Leadership at Evolve Biosystems

David MillsDavid MillsCo-Founder
David KyleDavid KyleBoard Member
Simon BarnesSimon BarnesBoard Member
Roger WyseRoger WyseBoard Member
Brent DreverBrent DreverBoard Member
Dan JanneyDan JanneyBoard Member

Catherine Mackey's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Catherine Mackey

Sean A. McCarthySean A. McCarthyBoard Member · CytomX TherapeuticsRemo Moomiaie-Qajar M.D.Remo Moomiaie-Qajar M.D.Co-Founder & CEO · Cytonus TherapeuticsBrian P McVeighBrian P McVeighBoard Member · GenisphereDon HardisonDon HardisonBoard Member · HTG Molecular DiagnosticsPaul CastellaPaul CastellaBoard Member · Hera BiotechMichael Forrest Ph.D.Michael Forrest Ph.D.Founder · Biophysical Therapeutics